
Sign up to save your podcasts
Or
Could a simple drug intended to treat cancer treatment complications be the next big breakthrough in Parkinson’s Disease treatment? Dr. Jonathan Sackner-Bernstein, MD, is leading research on tyrosine hydroxylase inhibition as a novel approach to managing Parkinson’s symptoms and slowing disease progression. Unlike traditional treatments that focus solely on replacing lost dopamine, a previously FDA approved drug (RB-190) targets tyrosine hydroxylase (TH)—the enzyme responsible for dopamine production—offering a new way to reduce dyskinesias, oxidative stress, and dopamine imbalances in the brain. Watch on YouTube
In this episode, we’ll break down:
✅ What tyrosine hydroxylase does and its role in dopamine production
✅ Why too much dopamine in certain brain regions can be problematic
✅ How RB-190 could change the way we treat Parkinson’s Disease
✅ The groundbreaking work of Dr. Sackner-Bernstein and what it means for the future
If you or a loved one is affected by Parkinson’s, this research could be a game-changer! Stay informed about the latest treatments and breakthroughs by liking, subscribing, and turning on notifications. You all will be the FIRST to know when phase IIA of the drug trials start and participants are needed. Follow Dr. Bernstein's blog here: https://www.parkinsonsdisease.blog/
🔔 Subscribe/follow for more Parkinson’s insights! 📢 Let us know in the comments—what do you think of this potential treatment?
Help to support this channel and out efforts to educate the world about Parkinson's Disease and get access to personalized content: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join
https://www.patreon.com/pdeducation
Please be sure to give support to our channel sponsors:
Comfort Linen: https://comfortlinen.com/PARKINSONSDISEASEEDUCATION (15% off entire order when applying the code PARKINSONSDISEASEEDUCATION at checkout)
Kizik Shoes: https://kizik.sjv.io/pdeducation
Cure Hydration: https://lvnta.com/lv_XG06Rho8SSlXEq3qlV
If you have products that you would like for me to review on the channel please send them here:
Parkinson's Disease Education
P.O. Box 1678
Broken Arrow, OK 74013
Medical Disclaimer: All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use
#parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #ParkinsonsDisease #Dopamine #TyrosineHydroxylase #JonathanSacknerBernstein #Neuroscience #MedicalBreakthrough
4.8
2626 ratings
Could a simple drug intended to treat cancer treatment complications be the next big breakthrough in Parkinson’s Disease treatment? Dr. Jonathan Sackner-Bernstein, MD, is leading research on tyrosine hydroxylase inhibition as a novel approach to managing Parkinson’s symptoms and slowing disease progression. Unlike traditional treatments that focus solely on replacing lost dopamine, a previously FDA approved drug (RB-190) targets tyrosine hydroxylase (TH)—the enzyme responsible for dopamine production—offering a new way to reduce dyskinesias, oxidative stress, and dopamine imbalances in the brain. Watch on YouTube
In this episode, we’ll break down:
✅ What tyrosine hydroxylase does and its role in dopamine production
✅ Why too much dopamine in certain brain regions can be problematic
✅ How RB-190 could change the way we treat Parkinson’s Disease
✅ The groundbreaking work of Dr. Sackner-Bernstein and what it means for the future
If you or a loved one is affected by Parkinson’s, this research could be a game-changer! Stay informed about the latest treatments and breakthroughs by liking, subscribing, and turning on notifications. You all will be the FIRST to know when phase IIA of the drug trials start and participants are needed. Follow Dr. Bernstein's blog here: https://www.parkinsonsdisease.blog/
🔔 Subscribe/follow for more Parkinson’s insights! 📢 Let us know in the comments—what do you think of this potential treatment?
Help to support this channel and out efforts to educate the world about Parkinson's Disease and get access to personalized content: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join
https://www.patreon.com/pdeducation
Please be sure to give support to our channel sponsors:
Comfort Linen: https://comfortlinen.com/PARKINSONSDISEASEEDUCATION (15% off entire order when applying the code PARKINSONSDISEASEEDUCATION at checkout)
Kizik Shoes: https://kizik.sjv.io/pdeducation
Cure Hydration: https://lvnta.com/lv_XG06Rho8SSlXEq3qlV
If you have products that you would like for me to review on the channel please send them here:
Parkinson's Disease Education
P.O. Box 1678
Broken Arrow, OK 74013
Medical Disclaimer: All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use
#parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #ParkinsonsDisease #Dopamine #TyrosineHydroxylase #JonathanSacknerBernstein #Neuroscience #MedicalBreakthrough
213 Listeners
138 Listeners
218 Listeners
177 Listeners
26 Listeners
23 Listeners
17 Listeners
1,921 Listeners
5 Listeners
40 Listeners
5 Listeners
110 Listeners
2 Listeners
9 Listeners
2 Listeners